NeuB
is a bacterial sialic acid synthase used by neuroinvasive
bacteria to synthesize N-acetylneuraminate (NeuNAc),
helping them to evade the host immune system. NeuNAc oxime is a potent
slow-binding NeuB inhibitor. It dissociated too slowly to be detected
experimentally, with initial estimates of its residence time in the
active site being >47 days. This is longer than the lifetime of
a
typical bacterial cell, meaning that inhibition is effectively irreversible.
Inhibition data fitted well to a model that included a pre-equilibration
step with a K
i of 36 μM, followed
by effectively irreversible conversion to an E*·I complex, with
a k
2 of 5.6 × 10–5 s–1. Thus, the inhibitor can subvert ligand release
and achieve extraordinary residence times in spite of a relatively
modest initial dissociation constant. The crystal structure showed
the oxime functional group occupying the phosphate-binding site normally
occupied by the substrate PEP and the tetrahedral intermediate. There
was an ≈10% residual rate at high inhibitor concentrations
regardless of how long NeuB and NeuNAc oxime were preincubated together.
However, complete inhibition was achieved by incubating NeuNAc oxime
with the actively catalyzing enzyme. This requirement for the enzyme
to be actively turning over for the inhibitor to bind to the second
subunit demonstrated an important role for intersubunit communication
in the inhibitory mechanism.